Birmingham, West Midlands -- (SBWIRE) -- 12/26/2013 -- Value Penny Stocks issues special report on MannKind Corporation (NASDAQ:MNKD), Enzon Pharmaceuticals Inc (NASDAQ:ENZN), Novavax, Inc. (NASDAQ:NVAX), Staples, Inc. (NASDAQ:SPLS).
MannKind Corporation (NASDAQ:MNKD) ended its recent business day with the gain of 2.14% and closed at the price of $5.25 after opening at $5.17. The stock traded during its last trading session with the total volume of 3.95 million shares, as compared to its average volume of 4.07 million shares. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
For How Long MNKD will Fight for Profitability? Read This Trend Analysis report
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) remained among the day advancers and traded with volume of 3.75 million shares in the last session, as compared to average volume of 304,587.00 shares. In comparison with 52 week range of $1.13 - $5.01, it faced lowest price of $1.13 during the last trading session whereas its day highest price was $1.29. The company’s total market capitalization is $50.68 billion, along with 44.07 million shares outstanding. Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the research and development of therapeutics for patients with unmet medical needs. The company was founded in 1981 and is headquartered in Piscataway, New Jersey.
For How Long ENZN’s Gloss will Attract Investors? Find out via this report
Novavax, Inc. (NASDAQ:NVAX) showed 3.61 million shares in volume during the last trading session, while the average trading volume remained 5.66 million shares. The stock kicked off its trading session at $5.14 and closed at $5.08 after mounting 0.79%. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Will NVAX Continue To Move Higher? Find Out Here
Staples, Inc. (NASDAQ:SPLS) stock traded during its last trading session with the total traded volume of 3.57 million shares versus its average volume of 9.12 million shares. The company opened its trade at the price of $15.69 and its closing price was $15.91 after gaining 0.63% for the day. Staples, Inc., together with its subsidiaries, operates as an office products company. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations.
Why Should Investors Buy SPLS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)